| Period Ending: |
LTM
(Last Twelve Months) |
2024 12-31 |
2023 12-31 |
2022 12-31 |
2021 12-31 |
2020 12-31 |
2019 12-31 |
|---|---|---|---|---|---|---|---|
| Report Filing | 2025-11-25 | 2025-04-15 | 2024-04-26 | 2023-04-28 | 2022-04-08 | 2020-12-31 | 2019-12-31 |
| Revenue | 2,970 | 3,650 | 4,198 | 3,668 | 2,921 | 1,278 | 668.7 |
| Cost of Revenue | 1,123 | 1,438 | 1,903 | 1,828 | 1,387 | 562 | 357.3 |
| Gross Profit | 1,847 | 2,212 | 2,296 | 1,840 | 1,534 | 716.4 | 311.4 |
| Operating Expenses | 2,077 | 2,700 | 3,368 | 3,472 | 2,906 | 1,286 | 1,367 |
| Research & Development | 549.1 | 742.9 | 901.3 | 776.8 | 611.6 | 311.8 | 350.1 |
| Selling, General and Administrative | 1,528 | 1,957 | 2,466 | 2,695 | 2,295 | 974.6 | 1,017 |
| Other Operating Expenses | 0 | -0 | 0 | 0 | 0 | -0 | 0 |
| Operating Income | -230.4 | -487.9 | -1,072 | -1,632 | -1,373 | -570 | -1,056 |
| Net Non-Operating Interest | 84.47 | 115 | 158.7 | 68.1 | 31.3 | 24.75 | 28.67 |
| Interest Income | 84.47 | 115 | 158.7 | 68.1 | 31.3 | 24.75 | 28.67 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity & Other Income/(Expense) | 274.9 | 192.1 | 85.82 | -27.88 | 64.71 | 56.94 | 25.48 |
| Income Before Tax | 129 | -180.9 | -827.6 | -1,592 | -1,277 | -488.3 | -1,001 |
| Income Tax Expense | 26.32 | -9.52 | 11.83 | 14.43 | 5.37 | 1.02 | 0.04 |
| Income Attributable to Non-Controlling Interest | 0.025 | 2.88 | 4.11 | 2.8 | 0 | 0 | 0 |
| Net Income | 102.6 | -174.2 | -843.5 | -1,609 | -1,282 | -489.3 | -1,002 |
| Depreciation and Amortization | 9.44 | 22.26 | 24.89 | 25.65 | 21.17 | 18.53 | 20.15 |
| EBITDA | -221 | -465.6 | -1,047 | -1,606 | -1,352 | -551.4 | -1,035 |
| Earnings Per Share (EPS) | 1.14 | -1.89 | -8.47 | -15.68 | -18.35 | -12.85 | -10.12 |
| Diluted Earnings Per Share | 1.11 | -1.89 | -8.47 | -15.68 | -18.35 | -12.85 | -10.12 |
| Weighted Average Shares Outstanding | 79.83 | 91.42 | 99.61 | 100.5 | 79.18 | 92.14 | 99.06 |
| Diluted Weighted Average Shares Outstanding | 79.83 | 91.42 | 99.61 | 100.5 | 79.18 | 92.14 | 99.06 |
